切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2019, Vol. 07 ›› Issue (01) : 64 -69. doi: 10.3877/cma.j.issn.2095-5782.2019.01.013

所属专题: 文献

肿瘤介入

超声引导下经皮激光消融治疗进展期胰腺癌的临床研究
安超1, 梁萍1,(), 于杰1,()   
  1. 1. 100853 北京,中国人民解放军总医院介入超声科
  • 收稿日期:2018-12-01 出版日期:2019-02-01
  • 通信作者: 梁萍, 于杰
  • 基金资助:
    国家自然科学基金(81430039、81627803、81801723)

Clinical research on ultrasound-guided percutaneous laser ablation for advanced pancreatic cancer

Chao An1, Ping Liang1,(), Jie Yu1,()   

  1. 1. Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, China
引用本文:

安超, 梁萍, 于杰. 超声引导下经皮激光消融治疗进展期胰腺癌的临床研究[J]. 中华介入放射学电子杂志, 2019, 07(01): 64-69.

Chao An, Ping Liang, Jie Yu. Clinical research on ultrasound-guided percutaneous laser ablation for advanced pancreatic cancer[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2019, 07(01): 64-69.

目的:

探讨超声引导下经皮激光消融治疗进展期胰腺癌的可行性、安全性和近期疗效。

方法:

研究采用前瞻性研究,选取2016年9月至2017年10月入住我院的7例进展期胰腺癌患者,于超声引导下采用经皮激光消融方法对其进行治疗,比较患者实施激光消融前后的实验室指标(CA-199、血清脂肪酶、淀粉酶和血糖),疼痛及生活质量评分,观察术后消融相关不良反应和主要并发症。

结果:

所有患者均成功完成激光消融术,技术成功率100%。行激光消融术前与术后的CA-199、血清脂肪酶、淀粉酶和血糖水平差异无统计学意义(P均>0.05)。患者术后1个月的躯体功能较术前改善[(50.0±0)分vs. (30.8±3.4)分],疼痛较术前缓解[(26.7±11.3)分vs.(61.9±16.3)分],差异有统计学意义(P均<0.05)。7例患者的总体生存时间为10个月(95%CI:5~13个月),在中位随访期9.7(6~15)个月内,4例患者分别在治疗后6.5、7.7、9.4和12.5个月死亡,余3例在随访期间仍然存活。术后未出现消融相关的主要并发症,术后3 d内出现与胃肠相关的不良反应包括恶心、腹痛及食欲不振,对症治疗后均好转。

结论:

激光消融治疗进展期胰腺癌可行性强,安全性高且近期疗效肯定,值得临床进一步推广。

Objective:

To investigate the feasibility, safety and short-term efficacy of ultrasound-guided percutaneous laser ablation for advanced pancreatic cancer.

Methods:

A prospective study was performed. Seven patients with advanced pancreatic cancer, who were admitted to our hospital from September 2016 to October 2017, were treated with ultrasound-guided percutaneous laser ablation. Laboratory indicators (CA-199, serum lipase, amylase and blood glucose) before and after ablation, pain, quality of life scores, postoperative ablation-related adverse events and major complications were observed.

Results:

All procedures were successfully completed by laser ablation with a technical success rate of 100%. There was no significant difference in CA-199, serum lipase, amylase and blood glucose levels before and after laser ablation (P>0.05) . The patient's physical function was improved after 1 month of surgery [ (50.0±0) points vs. (30.8±3.4) points], and the pain was relieved compared with preoperative[ (26.7±11.3) points vs. (61.9±16.3) points.], which had significant statistically difference (P<0.05) . The median overall survival time was 10 months (95%CI: 5-13 months) . During the median follow-up period of 9.7 (6 to 15) months, 4 patients were treated with 6.5, 7.7 and 9.4 months, respectively, and died in 12.5 months, the remaining 3 cases were still alive during the follow-up period. There were no major complications related to ablation after operation. Gastrointestinal-related adverse reactions including nausea, abdominal pain and loss of appetite within 3 d after surgery were improved after symptomatic treatment.

Conclusions:

Laser ablation is effective in the treatment of advanced pancreatic cancer, with high safety and short-term curative effect. It is worthy of further clinical promotion.

表1 7例患者的一般临床特征
表2 消融前后实验室检测指标的变化
表3 患者行激光消融术后生活质量评分的改变 (±s
图1 典型病例(男性,68岁,进展期胰腺癌)行激光消融术前术后的MRI图
图2 典型病例(女性,68岁,进展期胰腺癌伴有胆结石、糖尿病患者)行激光消融术前术后的表现
[1]
van Erning FN, Mackay TM, van der Geest LGM,et al. Association of the location of pancreatic ductal adenocarcinoma(head,body,tail)with tumor stage,treatment,and survival: a population-based analysis[J]. Acta Oncol,2018:1-8.
[2]
Sahin IH, Elias H, Chou JF,et al. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior[J]. BMC Cancer,2018,18(1):769.
[3]
He C, Zhang Y, Cai Z,et al. Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis[J]. J Cancer,2018,9(17):3156-3167.
[4]
Tempero MA, Malafa MP, Al-Hawary M,et al. Pancreatic Adenocarcinoma,Version 2.2017,NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw,2017,15(8):1028-1061.
[5]
Wang WQ, Liu L, Ni QX,et al. Guidelines for the diagnosis and treatment of pancreatic adenocarcinoma(2018 edition): A standardized procedure recommended in China[J]. HBPD INT,2018,17(5):383-384.
[6]
Al-Husseini MJ, Saad AM, Turk T,et al. Impact of prior malignancy on survival outcomes of stage IV pancreatic adenocarcinoma: SEER-Based Cohort[J]. J Gastrointest Cancer,2018. [Epub ahead of print]
[7]
Huang KW, Yang PC, Pua U,et al. The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma[J]. J Surg Oncol,2018,118(1):31-36.
[8]
D'Onofrio M, Barbi E, Girelli R,et al. Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma[J]. J Gastrointest Oncol,2016,7(2):213-220.
[9]
Nabavizadeh A, Payen T, Saharkhiz N,et al. Technical Note: In vivo Young's modulus mapping of pancreatic ductal adenocarcinoma during HIFU ablation using harmonic motion elastography(HME)[J]. Med Phys,2018,45(11):5244-5250.
[10]
Xu JB, Yang XC, Guo JH,et al. Serum nerve growth factor level indicates therapeutic efficacy of 125I seed implantation in advanced pancreatic adenocarcinoma[J]. Eur Rev Med Pharmacol Sci,2015,19(18):3385-3390.
[11]
Pacella CM. Ultrasound-guidedpercutonous laser ablation of liver tissue in a rabbit model[J]. European Radiology,1993,3(5):479-479.
[12]
Tian G, Jiang T. US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report[J]. Medicine(Baltimore),2017,96(15):e6597.
[13]
Morton LM, Kerns SL, Dolan ME. Role of germline genetics in identifying survivors at risk for adverse effects of cancer treatment[J]. Am Soc Clin Oncol Educ Book,2018,(38):775-786.
[14]
Morse B, Jeong D, Ihnat G,et al. Pearls and pitfalls of response evaluation criteria in solid tumors(RECIST)v1.1 non-target lesion assessment[J]. Abdom Radiol(NY),2018. [Epub ahead of print]
[15]
Mizota A, Takasoh M, Kobayashi K,et al. Internal sclerostomy with the Er: YAG laser using a gradient-index(GRIN)endoscope[J]. Ophthalmic Surg Lasers,2002,33(3):214-220.
[16]
Moyer MT, Sharzehi S, Mathew A,et al. The safety and efficacy of an alcohol-free pancreatic cyst ablation protocol[J]. Gastroenterology,2017,153(5):1295-1303.
[17]
Date RS, Siriwardena AK. Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome[J]. JOP,2005,6(6):588-592.
[18]
Spiliotis JD, Datsis AC, Michalopoulos NV,et al. Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas[J]. Langenbecks Arch Surg,2007,392(1):55-60.
[19]
Zou YP, Li WM, Zheng F,et al. Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer[J]. World J Gastroenterol,2010,16(40):5104-5110.
[20]
Schena E, Saccomandi P, Fong Y. Laser ablation for cancer: past,present and future[J]. J Funct Biomater,2017,8(2):E19.
[21]
Wang ZJ, Behr S, Consunji MV,et al. Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI[J]. AJR Am J Roentgenol,2018,211(5):1010-1019.
[1] 章美武, 吕淑懿, 范晓翔, 庄鲁辉, 裘玉琴, 张柏松, 张燕. 超声引导下抽液联合高渗葡萄糖冲洗治疗乳腺癌术后皮下积液的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(03): 327-331.
[2] 崔亭亭, 李俨育, 王茜, 傅晓凤, 范公林, 高力, 谢磊, 章德广, 朱江. 细针穿刺洗脱液甲状腺球蛋白诊断甲状腺乳头状癌颈部淋巴结转移的阈值及效能分析[J]. 中华医学超声杂志(电子版), 2023, 20(02): 219-226.
[3] 吴香敏, 吴鹏. 超声引导下收肌管阻滞联合腘动脉与膝关节后囊间隙阻滞在老年患者全膝关节置换术中的应用效果[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 516-522.
[4] 田发兰, 陈见中, 扎西卓玛, 喻定刚. 三维可视化技术在复杂泡型肝包虫病治疗中的临床应用[J]. 中华普通外科学文献(电子版), 2023, 17(04): 257-261.
[5] 齐普良, 田青山, 马丽娜, 李彩霞, 阿吉德. ICG示踪联合三维可视化技术指导下改良右半肝切除术治疗肝细胞癌的回顾性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 162-166.
[6] 黄新云, 覃丽云, 伍胜明, 隆宝田, 覃玉鸾, 唐娟, 廖芳, 韦新群, 谭宏兰, 蓝方成. 超声造影引导在微通道经皮肾镜碎石取石术中的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 114-118.
[7] 孔博, 张璟, 吕珂. 超声技术在复杂腹壁疝诊治中的作用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 670-673.
[8] 覃远浩, 梁予洁, 韦玲惠, 游志坚. 超声引导下腰方肌阻滞在儿童腹股沟疝术后镇痛的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(01): 74-78.
[9] 刘龙, 褚红军, 邢春花, 佘勇军. 超声引导下SAPB与ESPB在胸腔镜手术中的应用效果及术后疼痛分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 70-73.
[10] 孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇. ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 557-561.
[11] 高旭东, 王小明, 陈江明, 奚士航, 潘璇. 基于三维可视化技术的脾门区脾动脉三维分型[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 434-439.
[12] 储心昀, 李映安, 杨超, 戴已禾, 胡苹苹, 王峻峰, 晋云. 多影像融合超声引导激光消融精准治疗特殊部位肝癌疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 317-321.
[13] 萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398.
[14] 张勇创, 李威, 满文玲, 杨坡. 超声引导下微波消融治疗下肢静脉曲张的疗效观察[J]. 中华介入放射学电子杂志, 2023, 11(03): 218-222,246.
[15] 谭小云, 张靖, 刘珍银, 陈昆山, 夏杰军, 张明, 郭轶群, 陈穗颜. 盲法与超声引导下进行儿童股动脉穿刺的自身对照研究[J]. 中华介入放射学电子杂志, 2023, 11(01): 1-5,18.
阅读次数
全文


摘要